Literature DB >> 729627

Binding of drugs to human muscle.

B Fichtl, H Kurz.   

Abstract

Binding of 22 drugs to human muscle tissue has been determined by ultrafiltration. All drugs tested were bound, the bound fraction ranging from 13% (aminophenazone) to greater than 98% (desipramine). Both linear and nonlinear binding was observed. For chemically related substances, binding to muscle tissue correlated with plasma binding and lipid solubility. There were significant differences in binding to muscle from different individuals. With respect to pharmacokinetics of drugs, it is suggested that binding to muscle tissue may be at least as important as plasma binding.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729627     DOI: 10.1007/bf00611903

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  35 in total

1.  The interaction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions.

Authors:  L R GOLDBAUM; P K SMITH
Journal:  J Pharmacol Exp Ther       Date:  1954-06       Impact factor: 4.030

2.  The estimation of basic organic compounds in biological material; estimation by ultraviolet spectrophotometry.

Authors:  E S JOSEPHSON; S UDENFRIEND; B B BRODIE
Journal:  J Biol Chem       Date:  1947-04       Impact factor: 5.157

3.  The interactions of drugs and plasma proteins.

Authors:  A GOLDSTEIN
Journal:  J Pharmacol Exp Ther       Date:  1949-04       Impact factor: 4.030

4.  Hydrophobic interactions responsible for unspecific binding of morphine-like drugs.

Authors:  V Höllt; H Teschemacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 5.  [Plasma protein binding. Review].

Authors:  I von Schwarzenfeld
Journal:  Pharmazie       Date:  1974-08       Impact factor: 1.267

6.  Critical evaluation of use of effective protein fractions in developing pharmacokinetic models for drug distribution.

Authors:  D Shen; M Gibaldi
Journal:  J Pharm Sci       Date:  1974-11       Impact factor: 3.534

7.  Theoretical changes in drug distribution resulting from changes in binding to plasma proteins and to tissues.

Authors:  S H Curry
Journal:  J Pharm Pharmacol       Date:  1970-10       Impact factor: 3.765

Review 8.  The binding of drugs by plasma proteins.

Authors:  M C Meyer; D E Guttman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

9.  Species differences in the binding of phenylbutazone to plasma albumin.

Authors:  C F Chignell; D K Starkweather
Journal:  Pharmacology       Date:  1971       Impact factor: 2.547

10.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07
View more
  8 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

3.  Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.

Authors:  K Sakamoto; H Mikami; J Kimura
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

Review 4.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 6.  Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

Authors:  Marc Evans; Alan Rees
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  A physiological pharmacokinetic model for morphine disposition in the pregnant rat.

Authors:  J L Gabrielsson; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1983-04

8.  CSF and plasma pharmacokinetics of intramuscular morphine.

Authors:  G Nordberg; L Borg; T Hedner; T Mellstrand
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.